Levent Doğanay
- Epidemiology top 10%
- Molecular Biology
- Hepatology top 5%
- Endocrinology, Diabetes and Metabolism top 10%
- Infectious Diseases top 10%
- Co-authors
- İlyas TuncerOğuzhan ÖztürkYaşar ÇolakEbubekir ŞenateşFeruze Yılmaz EnçGizem Dinler DoğanayKâmil ÖzdilGupse Adalı
- Topics
- Liver Disease Diagnosis and Treatment (22 papers)Hepatitis B Virus Studies (16 papers)Hepatitis C virus research (14 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEFree Radical Biology and Medicine
- Partner nations
- TürkiyeUnited KingdomSweden
In The Last Decade
Levent Doğanay
61 papers receiving 934 citations
Peers
Comparison fields: 5 of 90
- Epidemiology 393
- Molecular Biology 171
- Hepatology 170
- Endocrinology, Diabetes and Metabolism 135
- Infectious Diseases 133
Countries citing papers authored by Levent Doğanay
This map shows the geographic impact of Levent Doğanay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levent Doğanay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levent Doğanay more than expected).
Fields of papers citing papers by Levent Doğanay
This network shows the impact of papers produced by Levent Doğanay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levent Doğanay. The network helps show where Levent Doğanay may publish in the future.
Co-authorship network of co-authors of Levent Doğanay
This figure shows the co-authorship network connecting the top 25 collaborators of Levent Doğanay. A scholar is included among the top collaborators of Levent Doğanay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levent Doğanay. Levent Doğanay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 7 | |
| 3 | 4 | |
| 4 | 9 | |
| 5 | 110 | |
| 6 | 15 | |
| 7 | 30 | |
| 8 | 23 | |
| 9 | 13 | |
| 10 | 7 | |
| 11 | 13 | |
| 12 | HLA DPB1 15:01 Allele Predicts Spontaneus Hepatitis B Surface Antigen Seroconversion. | 2 |
| 13 | 2 | |
| 14 | 2 | |
| 15 | 14 | |
| 16 | 5 | |
| 17 | 40 | |
| 18 | 24 | |
| 19 | 18 | |
| 20 | 29 |
About Levent Doğanay
Levent Doğanay is a scholar working on Hepatology, Epidemiology and Biological Psychiatry, having authored 62 papers that have together received 950 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (22 papers), Hepatitis B Virus Studies (16 papers) and Hepatitis C virus research (14 papers). The work is most often cited by research in Hepatology (170 citations), Geriatrics and Gerontology (76 citations) and Obstetrics and Gynecology (102 citations). Levent Doğanay has collaborated with scholars based in Türkiye, United Kingdom and Sweden. Frequent co-authors include İlyas Tuncer, Oğuzhan Öztürk, Yaşar Çolak, Ebubekir Şenateş, Feruze Yılmaz Enç, Gizem Dinler Doğanay, Kâmil Özdil, Gupse Adalı, Gizem Alkurt and Elif Yorulmaz. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.